Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2016

Apr 25, 2016

32939_dirs_2016-04-25_8151d127-4ae8-4456-b6d1-b56ee0aa507e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2016-04-21

Reporting Person: Trowbridge Stephen A (SVP and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-04-21 Common Stock S 10500 $12.33 Disposed 32469 Direct
2016-04-25 Common Stock S 2440 $12.18 Disposed 30029 Direct
2016-04-25 Common Stock F 1358 $12.23 Disposed 28671 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.33 to $12.34, inclusive. The reporting person undertakes to provide to AngioDynamics, Inc., any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The exempt disposition of 1,358 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on April 24, 2015.